Cannabis law can be complex and the regulatory landscape is constantly changing. Business owners in the sector face hurdles that most other types of businesses simply don’t face. Licensing regulations are only the first challenge.
Cannabis business owners must overcome issues such as zoning laws, local permit requirements, production limits and advertising/branding restrictions. Failure to comply can lead to license suspension or even harsh criminal penalties.
We have over a decade’s experience in preparing businesses for this, helping business owners incorporate and navigate the complex license application process. From small microbusinesses to larger enterprises, we have helped cannabis retail, cultivation, processing, manufacturing, distributing and testing operations become established.
We have also represented clients in civil lawsuits, administrative hearings and appeals in multiple states.
Due to our constant due diligence in staying up-to-date with national cannabis laws, we can help protect and minimize your risk and exposure at all stages of the business life cycle.
Expertise in the challenges of psychedelics therapies
Until recently, the use of substances with psychedelic properties was nearly always illegal but this is changing. There is a growing acceptance of the benefits of psychedelic therapies across the medical community in the U.S.
Psychedelics are proceeding toward legalization and decriminalization and the opportunities are expanding. Some cities across the country, such as Santa Cruz, Denver, Seattle, and Oakland have already decriminalized the usage of certain psychedelics. Other cities and states are expected to follow suit.
Our knowledge of psychedelic drugs and therapies and our experience in helping cannabis businesses get established across the country places us in a good position to assist clients in this growing area of treatment. This will only increase as more cities and states legalize medical and recreational usage.
However, the use of psychedelic drugs (“hallucinogens”) such as psilocybin, LSD, ketamine, DMT and MDMA in therapies is controversial as they remain Schedule I controlled substances at the federal level with various criminal statutes covering their usage and sale.
The early days of medical cannabis saw many similar challenges for early adopters. Despite the legal and regulatory requirements of such emerging therapies, the opportunities are tremendous for businesses that get in early and can navigate the legalities.
Few law firms are geared up to meet this growing demand for legal services related to the therapeutic use of hallucinogens. Our psychedelics attorneys can guide you through the state and federal legal hurdles of this emerging field — whether you’re a researcher, manufacturer, entrepreneur, investor, clinician or other stakeholder.
We can assist all relevant parties with every stage of the research, development, commercialization and medical practice involving psychedelics, providing a full suite of legal services.